Dietary protein defends lean mass and maintains the metabolic benefits of glucagon receptor agonism in mice
Objective: Glucagon has long been proposed as a component of multi-agonist obesity therapeutics due to its ability to induce energy expenditure and cause weight loss. However, chronic glucagon-receptor agonism has been associated with a reduction in circulating amino acids and loss of lean mass. Imp...
Saved in:
Main Authors: | Tatiana Lopes (Author), David CD. Hope (Author), Jose M. Ramos-Pittol (Author), Anna Curtis (Author), Jed V. Shrewsbury (Author), Iona Davies (Author), Zijing Zhou (Author), Alessandro Sardini (Author), James S. Minnion (Author), Dirk Dormann (Author), Gavin A. Bewick (Author), Kevin G. Murphy (Author), David Carling (Author), Stephen R. Bloom (Author), Tricia MM. Tan (Author), Bryn M. Owen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
by: Katrine D. Galsgaard, et al.
Published: (2022) -
Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats
by: Samantha L. Price, MRes, et al.
Published: (2015) -
Hepatocyte cholesterol content modulates glucagon receptor signalling
by: Emma Rose McGlone, et al.
Published: (2022) -
Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist
by: Phil Pickford, et al.
Published: (2021) -
Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling
by: Emma Rose McGlone, et al.
Published: (2021)